Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine.

Journal of psychopharmacology (Oxford, England) - 1 Aug 2007

Yoshida Keizo, Higuchi Hisashi, Kamata Mitsuhiro, Takahashi Hitoshi, Inoue Kazuyuki, Suzuki Toshio, Itoh Kunihiko, Ozaki Norio

Abstract excerpt

Prediction of the response to different classes of antidepressants has been an important matter of concern in the field of psychopharmacology. The purpose of the present study was to investigate whether the G196A polymorphism of the brain-derived neurotrophic factor (BDNF) gene is associated with the antidepressant effect of milnacipran, a serotonin norepinephrine reuptake inhibitor, and fluvoxamine, a selective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Brain-Derived Neurotrophic Factor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclopropanes

Share to Depression

Share to Fluvoxamine

Share to Patient Compliance

Share to Patient Selection

Share to Selective Serotonin Reuptake Inhibitors

Source

Identifiers

PMID: 17092970
DOI: 10.1177/0269881106072192

Genes

BDNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine.PMID 17092970Read ↗

[Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].Semantic proximity Read ↗

Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder.Semantic proximity Read ↗

Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response.Semantic proximity Read ↗

Analysis of genetic polymorphisms of brain-derived neurotrophic factor and methylenetetrahydrofolate reductase in depressed patients in a Slovak (Caucasian) population.Semantic proximity Read ↗

Effect of catechol-O-methyltransferase Val(108/158)Met polymorphism on antidepressant efficacy of fluvoxamine.Semantic proximity Read ↗

Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression.Semantic proximity Read ↗

Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity.Semantic proximity Read ↗

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.Semantic proximity Read ↗

Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to milnacipran and fluvoxamine in Japanese patients with depression.Semantic proximity Read ↗

The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients.Semantic proximity Read ↗

Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.Semantic proximity Read ↗

Association study between vesicle-associated membrane protein 2 gene polymorphisms and fluvoxamine response in Japanese major depressive patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.